Toshifumi Kudo

Toshifumi Kudo

Auto-generated profile, based on publicly available information

Toshifumi Kudo

Tokyo Medical and Dental University

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2014 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
KIKimihiro Igari
Kimihiro Igari
TKToshifumi Kudo
Toshifumi Kudo
HUHidetoshi Uchiyama
Hidetoshi Uchiyama
TTTakahiro Toyofuku
Takahiro Toyofuku
YIYoshinori Inoue
Yoshinori Inoue

1 August 2020 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
SHShoko Hara
Shoko Hara
KSKazuhide Shimizu
Kazuhide Shimizu
TNTadashi Nariai
Tadashi Nariai
MKMitsuhiro Kishino
Mitsuhiro Kishino
TKToshifumi Kudo
Toshifumi Kudo
TMTaketoshi Maehara
Taketoshi Maehara

31 July 2016 in International Journal of Vascular Medicine
Verified
Journal Article
Open access
PDF file
KIKimihiro Igari
Kimihiro Igari
TKToshifumi Kudo
Toshifumi Kudo
TTTakahiro Toyofuku
Takahiro Toyofuku
YIYoshinori Inoue
Yoshinori Inoue
Objective. The pentraxin family, including high-sensitivity C-reactive protein (hs-CRP), serum amyloid P (SAP), and pentraxin 3 (PTX3), has been identified as playing a key role in inflammatory reactions such as in atherosclerosis and cardiovascular disease. In this study, we examined the relationship between peripheral arterial disease (PAD) and serum levels of pentraxins.Methods. This study was undertaken via a retrospective review of PAD patients with surgical intervention for lesions of the common femoral artery. We evaluated the preoperative patient conditions, hemodynamic status, such as ankle brachial index (ABI), and clinical ischemic conditions according to Rutherford classification. Preoperatively, we collected blood samples for determining the serum levels of hs-CRP, SAP, and PTX3.Results. Twelve PAD patients with common femoral arterial lesions were treated and examined. The hemodynamic severity of PAD was not negatively correlated with hs-CRP, SAP, or PTX3. The clinical severity evaluated by Rutherford classification was significantly positively correlated with the serum level of PTX3 (p=0.019).Conclusion. We demonstrated that PTX3 might be a better marker of PAD than hs-CRP and SAP. Furthermore, PTX3 might be a prognostic marker to evaluate the severity of PAD.

3 July 2014 in Surgery Today
Verified
Journal Article
Closed access
PDF file
KIKimihiro Igari
Kimihiro Igari
TKToshifumi Kudo
Toshifumi Kudo
TTTakahito Toyofuku
Takahito Toyofuku
MJMasatoshi Jibiki
Masatoshi Jibiki
YIYoshinori Inoue
Yoshinori Inoue

18 October 2016 in International Journal of Vascular Medicine
Verified
Journal Article
Open access
PDF file
KIKimihiro Igari
Kimihiro Igari
TKToshifumi Kudo
Toshifumi Kudo
TTTakahiro Toyofuku
Takahiro Toyofuku
YIYoshinori Inoue
Yoshinori Inoue
Objective. Endothelial dysfunction plays a key role in atherosclerotic disease. Several methods have been reported to be useful for evaluating the endothelial dysfunction, and we investigated the endothelial dysfunction in patients with peripheral arterial disease (PAD) using peripheral arterial tonometry (PAT) test in this study. Furthermore, we examined the factors significantly correlated with PAT test.Methods. We performed PAT tests in 67 patients with PAD. In addition, we recorded the patients’ demographics, including comorbidities, and hemodynamical status, such as ankle brachial pressure index (ABI).Results. In a univariate analysis, the ABI value (r=0.271,P=0.029) and a history of cerebrovascular disease (r=0.208,P=0.143) were found to significantly correlate with PAT test, which calculated the reactive hyperemia index (RHI). In a multivariate analysis, only the ABI value significantly and independently correlated with RHI (β=0.254,P=0.041).Conclusion. This study showed a significant correlation between RHI and ABI. The PAT test is a useful tool for evaluating not only endothelial dysfunction but also the hemodynamical state in patients with PAD.

30 April 2015 in Case Reports in Vascular Medicine
Verified
Journal Article
Open access
PDF file
KIKimihiro Igari
Kimihiro Igari
TKToshifumi Kudo
Toshifumi Kudo
TTTakahiro Toyofuku
Takahiro Toyofuku
YIYoshinori Inoue
Yoshinori Inoue
Profunda femoris artery aneurysm (PFAA) is an extremely rare entity, with most cases being asymptomatic, which makes obtaining an early diagnosis difficult. We herein report a case series of PFAA, in which more than half of the PFAAs, which presented with no clinical symptoms, were discovered incidentally. All PFAAs were treated surgically with aneurysmectomy with or without vascular reconstruction. In cases involving a patent superficial femoral artery (SFA), graft replacement of the profunda femoris artery (PFA) is not mandatory; however, preserving the blood flow of the PFA is necessary to maintain lower extremity perfusion in patients with occlusion of the SFA. Therefore, the treatment of PFAAs should include appropriate management of both the aneurysmectomy and graft replacement, if possible.